Chaperonin containing TCP1 subunit 3 (CCT3) promotes cisplatin resistance of lung adenocarcinoma cells through targeting the Janus kinase 2/signal transducers and activators of transcription 3 (JAK2/STAT3) pathway

Cisplatin resistance remains a major obstacle to effective chemotherapies for non-small cell lung cancer (NSCLC). Chaperonin containing TCP1 subunit 3 (CCT3) has been extensively investigated in various cancers, but not in the context of drug resistance. In the present study, we aimed to investigate...

Descripción completa

Detalles Bibliográficos
Autores principales: Danni, Xu, Jiangzheng, Zeng, Huamao, Sun, Yinglian, Pan, Changcheng, Yang, Yanda, Lu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806702/
https://www.ncbi.nlm.nih.gov/pubmed/34612768
http://dx.doi.org/10.1080/21655979.2021.1971030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806702/
https://www.ncbi.nlm.nih.gov/pubmed/34612768
http://dx.doi.org/10.1080/21655979.2021.1971030

Ejemplares similares